ArticleScientific reports2025
Development of a direct whole genome sequencing for hepatitis A virus from serum and analysis of genetic characteristics.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evolving trends in hepatitis A epidemiology: Shifting patterns, emerging risks, and future strategies.World journal of virology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Hepatitis A virus (HAV) is transmitted via the fecal-oral route, including through person-to-person contact and consumption of contaminated food. In 2019, 17,638 cases of HAV infection were reported in South Korea. The use of whole-genome sequencing (WGS) for rapid and accurate epidemiological investigation of HAV remains challenging due to the low viral titers and the lack of a cell culture system. Here, we developed a multiplex PCR (mPCR)-based next generation sequencing (NGS) method for direct WGS of HAV from serum using the Illumina platform. Overlapping primers were designed to generate amplicons covering the entire HAV genome, enabling successful sequencing from samples with viral titers as low as 3.0 log
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.